In vitro and in vivo suppression of SARS‐CoV‐2 replication by a modified, short, cell‐penetrating peptide targeting the C‐terminal domain of the viral spike protein
Peptides are promising therapeutic agents for COVID‐19 because of their specificity, easy
synthesis, and ability to be fine‐tuned. We previously demonstrated that a cell‐permeable …
synthesis, and ability to be fine‐tuned. We previously demonstrated that a cell‐permeable …
In vitro and in vivo suppression of SARS-CoV-2 replication by a modified, short, cell-penetrating peptide targeting the C-terminal domain of the viral spike protein
D Kim, J Kim, S An, M Kim, K Baek… - Journal of Medical …, 2023 - pure.korea.ac.kr
Peptides are promising therapeutic agents for COVID-19 because of their specificity, easy
synthesis, and ability to be fine-tuned. We previously demonstrated that a cell-permeable …
synthesis, and ability to be fine-tuned. We previously demonstrated that a cell-permeable …
In vitro and in vivo suppression of SARS-CoV-2 replication by a modified, short, cell-penetrating peptide targeting the C-terminal domain of the viral spike protein.
D Kim, J Kim, S An, M Kim, K Baek, BM Kang… - 2023 - cabidigitallibrary.org
Peptides are promising therapeutic agents for COVID-19 because of their specificity, easy
synthesis, and ability to be fine-tuned. We previously demonstrated that a cell-permeable …
synthesis, and ability to be fine-tuned. We previously demonstrated that a cell-permeable …
In vitro and in vivo suppression of SARS-CoV-2 replication by a modified, short, cell-penetrating peptide targeting the C-terminal domain of the viral spike protein.
D Kim, J Kim, S An, M Kim, K Baek… - Journal of Medical …, 2023 - europepmc.org
Peptides are promising therapeutic agents for COVID-19 because of their specificity, easy
synthesis, and ability to be fine-tuned. We previously demonstrated that a cell-permeable …
synthesis, and ability to be fine-tuned. We previously demonstrated that a cell-permeable …
In vitro and in vivo suppression of SARS‐CoV‐2 replication by a modified, short, cell‐penetrating peptide targeting the C‐terminal domain of the viral spike protein.
D Kim, J Kim, S An, M Kim, K Baek… - Journal of Medical …, 2023 - search.ebscohost.com
Peptides are promising therapeutic agents for COVID‐19 because of their specificity, easy
synthesis, and ability to be fine‐tuned. We previously demonstrated that a cell‐permeable …
synthesis, and ability to be fine‐tuned. We previously demonstrated that a cell‐permeable …
In vitro and in vivo suppression of SARS-CoV-2 replication by a modified, short, cell-penetrating peptide targeting the C-terminal domain of the viral spike protein
D Kim, J Kim, S An, M Kim, K Baek… - Journal of medical …, 2023 - pubmed.ncbi.nlm.nih.gov
Peptides are promising therapeutic agents for COVID-19 because of their specificity, easy
synthesis, and ability to be fine-tuned. We previously demonstrated that a cell-permeable …
synthesis, and ability to be fine-tuned. We previously demonstrated that a cell-permeable …